Swedish biotech BioLamina pens EIB venture debt deal
EIB has lent €20 million ($23.56 million) to Swedish biotechnology company BioLamina to expand development of laminin technologies supporting...
EIB has lent €20 million ($23.56 million) to Swedish biotechnology company BioLamina to expand development of laminin technologies supporting...